The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene
Open accessAbstract
In the Western world, an average of 250 mg per day of triterpenes (member of phytosterol family), largely derived from vegetable oils, cereals, fruits and vegetables is consumed by humans. During the last decade, there has been an unprecedented escalation of interest in triterpenes due to their cholesterol-lowering properties and evidence of this phenomenon include at least 25 clinical studies, 20 patents and at least 10 major commercially triterpene-based products currently being sold all around the world. Lupeol a triterpene [also known as Fagarsterol] found in white cabbage, green pepper, strawberry, olive, mangoes and grapes was reported to possess beneficial effects as a therapeutic and preventive agent for a range of disorders. Last 15 years have seen tremendous efforts by researchers worldwide to develop this wonderful molecule for its clinical use for the treatment of variety of disorders. These studies also provide insight into the mechanism of action of Lupeol and suggest that it is a multi-target agent with immense anti-inflammatory potential targeting key molecular pathways which involve nuclear factor kappa B (NFκB), cFLIP, Fas, Kras, phosphatidylinositol-3-kinase (PI3K)/Akt and Wnt/β-catenin in a variety of cells. It is noteworthy that Lupeol at its effective therapeutic doses exhibit no toxicity to normal cells and tissues. This mini review provides detailed account of preclinical studies conducted to determine the utility of Lupeol as a therapeutic and chemopreventive agent for the treatment of inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Prasad, S., Nigam, N., Kalra, N., & Shukla, Y. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20442 · Cited by 52
RetractedMoreau, R. A., Whitaker, B. D., & Hicks, K. B. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00006-1 · Cited by 1,159
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
The analysis of onion and garlic
Lanzotti, V. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.12.016 · Cited by 945
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637 · cited 6×
“Recent studies have shown that diets rich in phytochemicals can significantly reduce cancer risk by as much as 20% [2,31,32].”
BackgroundInfluentialPonder, B. A. J. (2001) · Nature · doi:10.1038/35077207 · Cited by 446
Sporn, M. B., & Suh, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.525 · Cited by 439
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Ma, J., & Waxman, D. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0715 · Cited by 370
Phytosterols as anticancer compounds
Bradford, P. G., & Awad, A. B. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600164 · Cited by 351
Active components and clinical applications of olive oil.
Waterman, E., & Lockwood, B. (2007) · PubMed · Cited by 350
Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects
Akihisa, T., Yasukawa, K., Oinuma, H., Kasahara, Y., Yamanouchi, S., Takido, M., Kumaki, K., & Tamura, T. (1996) · Phytochemistry · doi:10.1016/s0031-9422(96)00343-3 · Cited by 273
Biologically active pentacyclic triterpenes and their current medicine signification
Patočka, J. (2003) · Journal of Applied Biomedicine · doi:10.32725/jab.2003.002 · Cited by 268
Bauvois, B., & Dauzonne, D. (2006) · Medicinal Research Reviews · doi:10.1002/med.20044 · Cited by 266
Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice
Saleem, M., Afaq, F., Adhami, V. M., & Mukhtar, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207641 · Cited by 253
Self-citationPentacyclic triterpenoic acids: new chemoprotective compounds. Minireview.
Ovesná, Z., Vachálková, A., Horváthová, K., & Tóthová, D. (2004) · PubMed · Cited by 251
New insights into the mechanism of action of the anti-inflammatory triterpene lupeol
Fernández, M. A., de las Heras, B., Garcia, M. D., Sáenz, M. T., & Villar, A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011777909 · Cited by 205
Plant-Derived Triterpenoids as Potential Antineoplastic Agents
Setzer, W., & Setzer, M. (2003) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557033487854 · Cited by 186
Phytosterol Content in American Ginseng Seed Oil
Beveridge, T. H. J., Li, T. S. C., & Drover, J. C. G. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010701v · Cited by 174
Saleem, M., Kaur, S., Kweon, M., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi157 · Cited by 139
Self-citationSaleem, M., Maddodi, N., Zaid, M. I. A., Khan, N., Hafeez, B. B., Asim, M., Suh, Y. K., Yun, J., Setaluri, V., & Mukhtar, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4413 · Cited by 137
Self-citationLupeol ameliorates aflatoxin B1-induced peroxidative hepatic damage in rats
Preetha, S. P., Kanniappan, M., Selvakumar, E., Nagaraj, M., & Varalakshmi, P. (2006) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2006.03.008 · Cited by 135
Saleem, M., Kweon, M., Yun, J., Adhami, V. M., Khan, N., Syed, D. N., & Mukhtar, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1965 · Cited by 131
Self-citationLiquorice and its health implications
Olukoga, A. O., & Donaldson, D. I. (2000) · The Journal of the Royal Society for the Promotion of Health · doi:10.1177/146642400012000203 · Cited by 130
Lee, T. K., Poon, R. T. P., Wo, J. Y. H., Ma, S., Guan, X., Myers, J. N., Altevogt, P., & Yuen, A. P. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0801 · Cited by 117
Antitumor Activity of Bruceantin: An Old Drug with New Promise,
Cuendet, M., & Pezzuto, J. M. (2003) · Journal of Natural Products · doi:10.1021/np030304+ · Cited by 117
Ahn, K. S., Sethi, G., & Aggarwal, B. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.010 · Cited by 114
Harish, B. G., Krishna, V., Kumar, H., et al. (2008) · Phytomedicine · doi:10.1016/j.phymed.2007.11.017 · Cited by 108
Sudhahar, V., Kumar, S. A., Sudharsan, P. T., & Varalakshmi, P. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2006.12.005 · Cited by 100
Nguemfo, E. L., Dimo, T., Dongmo, A. B., Azébazé, A. G. B., Alaoui, K., Asongalem, A. E., Cherrah, Y., & Kamtchouing, P. (2008) · Inflammopharmacology · doi:10.1007/s10787-008-8039-2 · Cited by 100
Molnar, J. A., Gyémánt, N., Tanaka, M., Hohmann, J., Bergmann‐Leitner, E. S., Molnár, P., Deli, J., Didiziapetris, R., & Ferreira, M. U. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775201893 · Cited by 99
The triterpenoid lupeol attenuates allergic airway inflammation in a murine model
Vasconcelos, J. F., Teixeira, M. M., Barbosa‐Filho, J. M., Lúcio, A. S. S. C., Almeida, J. R. G. D. S., de Queiroz, L. P., Ribeiro‐dos‐Santos, R., & Soares, M. B. P. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.04.011 · Cited by 99
Murtaza, I., Saleem, M., Adhami, V. M., Hafeez, B. B., & Mukhtar, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2917 · Cited by 97
Self-citationLupeol inhibits proliferation of human prostate cancer cells by targeting -catenin signaling
Saleem, M., Murtaza, I., Tarapore, R. S., Suh, Y., Adhami, V. M., Johnson, J. J., Siddiqui, I. A., Khan, N., Asim, M., Hafeez, B. B., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp044 · Cited by 94
Self-citationPrasad, S., Kalra, N., Singh, M., & Shukla, Y. (2008) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2008.00313.x · Cited by 78
Nikiema, J. B., Vanhaelen‐Fastré, R., Vanhaelen, M. H., et al. (2001) · Phytotherapy Research · doi:10.1002/ptr.700 · Cited by 77
Protective effect of lupeol and lupeol linoleate in hypercholesterolemia associated renal damage
Varadarajan, S., Kumar, S. A., Varalakshmi, P., & Sujatha, V. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9786-5 · Cited by 75
Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin
Nigam, N., Prasad, S., & Shukla, Y. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.06.002 · Cited by 74
Suppression of T lymphocyte activity by lupeol isolated fromCrataeva religiosa
Bani, S., Kaul, A., Khan, B., Ahmad, S. F., Suri, K. A., Gupta, B. D., Satti, N. K., & Qazi, G. N. (2006) · Phytotherapy Research · doi:10.1002/ptr.1852 · Cited by 74
Anti-inflammatory effect of Pimenta racemosa var. ozua and isolation of the triterpene lupeol
Fernández, Á., Álvarez, A., García, M. D., & Sáenz, M. T. (2001) · Il Farmaco · doi:10.1016/s0014-827x(01)01080-1 · Cited by 72
Geetha, T., Varalakshmi, P., & LATHA, R. M. (1998) · Pharmacological Research · doi:10.1006/phrs.1997.0278 · Cited by 71
Aloe vera, hydrocortisone, and sterol influence on wound tensile strength and anti-inflammation
Davis, R., DiDonato, J., Johnson, R., & Stewart, C. (1994) · Journal of the American Podiatric Medical Association · doi:10.7547/87507315-84-12-614 · Cited by 71
The role of genomic instability in human carcinogenesis.
Coleman, W. B., & Tsongalis, G. J. (1999) · PubMed · Cited by 71
Yamashita, K., Lu, H., Lu, J., Chen, G., Yokoyama, T., Sagara, Y., Manabe, M., & Kodama, H. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00252-8 · Cited by 66
Lima, L. M., Perazzo, F. F., Carvalho, J. C. T., & Bastos, J. K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.8.0014 · Cited by 63
Zhang, L., Zhang, Y., Zhang, L., Yang, X., & Lv, Z.-C. (2009) · Cancer Investigation · doi:10.1080/07357900802210745 · Cited by 60
From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy
Georgakis, G. V., & Younes, A. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.1.131 · Cited by 55
Sudharsan, P. T., Mythili, Y., Elangovan, S., & Varalakshmi, P. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000200658.89629.ba · Cited by 46
Remodeling of Actin Cytoskeleton in Lupeol-Induced B16 2F2 Cell Differentiation
Hata, K., Hori, K., Murata, J., & Takahashi, S. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi151 · Cited by 40
Vidya, L., Mahimainathan, L., & Varalakshmi, P. (2002) · Phytotherapy Research · doi:10.1002/ptr.940 · Cited by 38
Al‐Rehaily, A. J., ElTahir, K. E. H., Mossa, J. S., & Rafatullah, S. (2001) · Natural Product Sciences · Cited by 25
Patočka, J. (1999) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2019.154 · Cited by 19
Cited by
Oxidative Cyclization in Natural Product Biosynthesis
Tang, M.-C., Zou, Y., Watanabe, K., Walsh, C. T., & Tang, Y. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00478 · Cited by 425
Beneficial health effects of lupeol triterpene: A review of preclinical studies
Siddique, H. R., & Saleem, M. (2011) · Life Sciences · doi:10.1016/j.lfs.2010.11.020 · Cited by 369
Self-citationThe saponins – polar isoprenoids with important and diverse biological activities
Osbourn, A., Goss, R. J. M., & Field, R. A. (2011) · Natural Product Reports · doi:10.1039/c1np00015b · Cited by 282
Why is sea buckthorn (Hippophae rhamnoides L.) so exceptional? A review
Ciesarová, Z., Murkovic, M., Cejpek, K., Kreps, F., Tobolková, B., Koplík, R., Belajová, E., Kukurová, K., Daško, Ľ., Panovská, Z., et al. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109170 · Cited by 268
Utilization of banana waste as a resource material for biofuels and other value-added products
Gupta, G., Baranwal, M., Saxena, S., & Reddy, M. S. (2023) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-02306-6 · Cited by 83
Metadata
- Authors
- Saleem, M.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 285
- Issue
- 2
- Pages
- 109-115
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1982415074
- Cited by
- 638
- References
- 52
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.